Re: [tips] B vitamins, Alzheimer's, and telling the whole story

2010-09-10 Thread Allen Esterson
Stephen: Thanks for your analysis of the B vitamins and Alzheimer's 
study as reported.

Query re cognitive impairment: Is it possible that previous studies 
showing some correlation between brain atrophy and the likelihood of 
developing Alzheimer's is relevant to the claims?

http://brain.oxfordjournals.org/content/132/8/2026.short

http://radiology.rsna.org/content/229/3/691.full

Allen Esterson
Former lecturer, Science Department
Southwark College, London
allenester...@compuserve.com
http://www.esterson.org

---
[tips] B vitamins, Alzheimer's, and telling the whole story
sblack
Thu, 09 Sep 2010 22:46:47 -0700
Our CTV television network, which prides itself in presenting the
very latest in medical advances, adequate evidence or not,  had
another one tonight. A randomized controlled study which
showed that a 2-year regimen of B vitamins in the elderly with
mild cognitive impairment slows the rate of MRI-assessed brain
atrophy.

But funny, I said to my wife, there's no mention of cognitive
improvement. Surely in a clinical study of this size and
sophistication, not to mention expense,  they would measure
cognition before and after treatment.  And if they did, wouldn't
they be bound to mention the outcome? Think again.

The study turns out to be Smith et al (2010). They took a battery
of cognitive measures, all right, but there was nothing in the
methods I could see noting that they took these measures after
treatment as well as before.  But apparently they did.

Buried in a section labeled secondary outcomes was this
statement Although the study was not powered to detect an
effect of treatment on cognition (findings to be reported
separately), in a post hoc analysis we noted that final cognitive
test scores were correlated to rate of atrophy.

My translation: We didn't find any difference between placebo
and vitamin treatments in cognition, so we did what we could to
put a positive spin on this, and also to forget about it. Anyway, if
we had more subjects, we might have seen something  (the not
powered excuse).

They provide a brief similar excuse (not powered to detect
effects of treatment on cognitive test scores) in a later section
titled Possible therapeutic implications. No data, of course.

But curiously, if one goes to where they registered their trial
before it began, they specified that in their study a primary
outcome measure was Changes in performance on a variety
of cognitive tests. Nothing there about not powered.

See:
http://www.controlled-trials.com/ISRCTN94410159/94410159

So it seems that in their haste to get out the good news
(vitamins slow brain atrophy, which is indeed impressive), they
somehow avoided providing the bad news (no detectable effect
on cognition). Perhaps providing it would tend to dampen sales
for the products for which Dr. Smith is listed as inventor with
patents held by the University of Oxford and on which he could
benefit financially (see competing interests).


Stephen


Smith, A. et al (2010). Homocysteine-lowering by B vitamins
slows the rate of accelerated brain atrophy in mild cognitive
impairment: a randomized controlled tria. PLoS ONE,
September 2010, v. 5, issue 9, e1244

Available here:
http://tinyurl.com/Bvitamins-for-the-brain


Stephen L. Black, Ph.D.
Professor of Psychology, Emeritus
Bishop's University
e-mail:  sblack at ubishops.ca
2600 College St.
Sherbrooke QC  J1M 1Z7
Canada



---
You are currently subscribed to tips as: arch...@jab.org.
To unsubscribe click here: 
http://fsulist.frostburg.edu/u?id=13090.68da6e6e5325aa33287ff385b70df5d5n=Tl=tipso=4702
or send a blank email to 
leave-4702-13090.68da6e6e5325aa33287ff385b70df...@fsulist.frostburg.edu


Re: [tips] B vitamins, Alzheimer's, and telling the whole story

2010-09-10 Thread roig-reardon


And some continue to wonder why the public is losing its trust in science ... 



Miguel 




- Original Message - 
From: sbl...@ubishops.ca 
To: Teaching in the Psychological Sciences (TIPS) 
tips@fsulist.frostburg.edu 
Sent: Friday, September 10, 2010 1:46:15 AM 
Subject: [tips] B vitamins, Alzheimer's, and telling the whole story 

Our CTV television network, which prides itself in presenting the 
very latest in medical advances, adequate evidence or not,  had 
another one tonight. A randomized controlled study which 
showed that a 2-year regimen of B vitamins in the elderly with 
mild cognitive impairment slows the rate of MRI-assessed brain 
atrophy. 

But funny, I said to my wife, there's no mention of cognitive 
improvement. Surely in a clinical study of this size and 
sophistication, not to mention expense,  they would measure 
cognition before and after treatment.  And if they did, wouldn't 
they be bound to mention the outcome? Think again. 

The study turns out to be Smith et al (2010). They took a battery 
of cognitive measures, all right, but there was nothing in the 
methods I could see noting that they took these measures after 
treatment as well as before.  But apparently they did. 

Buried in a section labeled secondary outcomes was this 
statement Although the study was not powered to detect an 
effect of treatment on cognition (findings to be reported 
separately), in a post hoc analysis we noted that final cognitive 
test scores were correlated to rate of atrophy. 

My translation: We didn't find any difference between placebo 
and vitamin treatments in cognition, so we did what we could to 
put a positive spin on this, and also to forget about it. Anyway, if 
we had more subjects, we might have seen something  (the not 
powered excuse). 

They provide a brief similar excuse (not powered to detect 
effects of treatment on cognitive test scores) in a later section 
titled Possible therapeutic implications. No data, of course. 

But curiously, if one goes to where they registered their trial 
before it began, they specified that in their study a primary 
outcome measure was Changes in performance on a variety 
of cognitive tests. Nothing there about not powered. 

See: 
http://www.controlled-trials.com/ISRCTN94410159/94410159 

So it seems that in their haste to get out the good news 
(vitamins slow brain atrophy, which is indeed impressive), they 
somehow avoided providing the bad news (no detectable effect 
on cognition). Perhaps providing it would tend to dampen sales 
for the products for which Dr. Smith is listed as inventor with 
patents held by the University of Oxford and on which he could 
benefit financially (see competing interests). 


Stephen 


Smith, A. et al (2010). Homocysteine-lowering by B vitamins 
slows the rate of accelerated brain atrophy in mild cognitive 
impairment: a randomized controlled tria. PLoS ONE, 
September 2010, v. 5, issue 9, e1244 

Available here: 
http://tinyurl.com/Bvitamins-for-the-brain 

 
Stephen L. Black, Ph.D.           
Professor of Psychology, Emeritus   
Bishop's University               
e-mail:  sblack at ubishops.ca 
2600 College St. 
Sherbrooke QC  J1M 1Z7 
Canada 
--- 

--- 
You are currently subscribed to tips as: roig-rear...@comcast.net. 
To unsubscribe click here: 
http://fsulist.frostburg.edu/u?id=13482.917fac06d4daae681dabfe964ca8c74en=Tl=tipso=4700
 
or send a blank email to 
leave-4700-13482.917fac06d4daae681dabfe964ca8c...@fsulist.frostburg.edu 

---
You are currently subscribed to tips as: arch...@jab.org.
To unsubscribe click here: 
http://fsulist.frostburg.edu/u?id=13090.68da6e6e5325aa33287ff385b70df5d5n=Tl=tipso=4704
or send a blank email to 
leave-4704-13090.68da6e6e5325aa33287ff385b70df...@fsulist.frostburg.edu

Re: [tips] B vitamins, Alzheimer's, and telling the whole story

2010-09-10 Thread sblack
On 10 Sep 2010 at 3:08, Allen Esterson wrote:

 
 Query re cognitive impairment: Is it possible that previous studies 
 showing some correlation between brain atrophy and the likelihood of 
 developing Alzheimer's is relevant to the claims?
 
 http://brain.oxfordjournals.org/content/132/8/2026.short
 
 http://radiology.rsna.org/content/229/3/691.full
 

Interesting. But predictive is not the same as causes.  And 
note that while they're happy to tell us about this encouraging-
sounding correlation, they're somehow unable to provide a clear 
statement that they failed to find a difference between placebo 
and drug.

The larger point is not that they can't be allowed some wiggle 
room.  It may well be that their sample size was too small to 
detect a cognitive effect, or that they didn't continue the trial long 
enough (However, I understand that the prior evidence for B-
vitamins for Alzheimer's is not encouraging.)

No, the problem is that they instead buried this inconvenient 
finding.  Imagine that they did find a positive effect. Would you 
find a similar reticence to mention it alongside the brain results? 

I won't hold my breath waiting for those promised negative 
findings to be reported separately. But even if they do appear, 
how much publicity do you think they will generate split off from 
the rest of the study?

I now see that _New Scientist_  (NS) has also expressed 
reservations about the study, but I'd say they got it wrong. 
(See http://tinyurl.com/NewScientisttake  ). 

NS complained that the sample was too small for the brain 
atrophy results. Actually, getting an effect with a small sample 
means the finding must be robust.  Also, as we're not talking 
about  a clinical drug effect, criticizing Smith et al by saying the 
absolute difference in atrophy size is small is not a persuasive 
criticism. But NS do incorrectly say that no cognitive tests were 
done. This makes my point.  Smith et al's write-up seems to 
have misled them. 

Bottom line: If you say in advance that cognitive changes are 
one of your primary outcome measures (and you should), you'd 
better report 'em, even if you don't like the way they turned out. 
And even if doing so will dampen enthusiasm for buying said 
vitamins.

Stephen

Stephen L. Black, Ph.D.  
Professor of Psychology, Emeritus   
Bishop's University   
e-mail:  sblack at ubishops.ca
2600 College St.
Sherbrooke QC  J1M 1Z7
Canada
---

---
You are currently subscribed to tips as: arch...@jab.org.
To unsubscribe click here: 
http://fsulist.frostburg.edu/u?id=13090.68da6e6e5325aa33287ff385b70df5d5n=Tl=tipso=4718
or send a blank email to 
leave-4718-13090.68da6e6e5325aa33287ff385b70df...@fsulist.frostburg.edu


[tips] TIPSTER OF THE WEEK

2010-09-10 Thread michael sylvester
 ANNETTE   FUJAWSKI   TAYLOR

Michael  omnicentric  Sylvester,PhD
Daytona Beach,Florida
---
You are currently subscribed to tips as: arch...@jab.org.
To unsubscribe click here: 
http://fsulist.frostburg.edu/u?id=13090.68da6e6e5325aa33287ff385b70df5d5n=Tl=tipso=4721
or send a blank email to 
leave-4721-13090.68da6e6e5325aa33287ff385b70df...@fsulist.frostburg.edu

[tips] Ronald Reagan 101 for Gainesville participants

2010-09-10 Thread michael sylvester
TRUST  BUT  VERIFY!

Michael omnicentric Sylvester,PhD
Daytona Beach,Florida
---
You are currently subscribed to tips as: arch...@jab.org.
To unsubscribe click here: 
http://fsulist.frostburg.edu/u?id=13090.68da6e6e5325aa33287ff385b70df5d5n=Tl=tipso=4722
or send a blank email to 
leave-4722-13090.68da6e6e5325aa33287ff385b70df...@fsulist.frostburg.edu

Re: [tips] TIPSTER OF THE WEEK

2010-09-10 Thread Ken Steele


Yo Fike:

It's a 'K'


On 9/10/2010 7:54 PM, michael sylvester wrote:




ANNETTE FUJAWSKI TAYLOR
Michael omnicentric Sylvester,PhD
Daytona Beach,Florida

---



---
You are currently subscribed to tips as: arch...@jab.org.
To unsubscribe click here: 
http://fsulist.frostburg.edu/u?id=13090.68da6e6e5325aa33287ff385b70df5d5n=Tl=tipso=4723
or send a blank email to 
leave-4723-13090.68da6e6e5325aa33287ff385b70df...@fsulist.frostburg.edu


Re: [tips] B vitamins, Alzheimer's, and telling the whole story

2010-09-10 Thread michael sylvester

Snake oil,snakoil,snake oil.

Michael



---
You are currently subscribed to tips as: arch...@jab.org.
To unsubscribe click here: 
http://fsulist.frostburg.edu/u?id=13090.68da6e6e5325aa33287ff385b70df5d5n=Tl=tipso=4724
or send a blank email to 
leave-4724-13090.68da6e6e5325aa33287ff385b70df...@fsulist.frostburg.edu